ArticleJapanese journal of ophthalmology2013
Recovery from deepening of the upper eyelid sulcus after switching from bimatoprost to latanoprost.
Article in Japanese journal of ophthalmology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 49 citations in OpenAlex.
- Impact of prostaglandin-related antiglaucoma medication use on levator aponeurosis advancement outcomes.International ophthalmology · 2026Article
- A Comprehensive Review of the Clinical Evidence Comparing Benzalkonium Chloride-Preserved and Benzalkonium Chloride-Free Latanoprost in the Treatment of Primary Open-Angle Glaucoma and Ocular Hypertension.Clinical ophthalmology (Auckland, N.Z.) · 2026Review
- Five-Year Outcomes of Omidenepag Isopropyl Monotherapy for Untreated Primary Open-Angle Glaucoma.Cureus · 2025Article
- Oculoplastic Challenges in Patients with Glaucoma.Turkish journal of ophthalmology · 2025Review
- Relationship Between Intraocular Pressure-Lowering Effects and Alterations in Anterior Segment Scleral Birefringence Following Micropulse Cyclophotocoagulation.Clinical ophthalmology (Auckland, N.Z.) · 2025Article
- From Eye Care to Hair Growth: Bimatoprost.Pharmaceuticals (Basel, Switzerland) · 2024Review
- Improvement of Prostaglandin-Associated Periorbitopathy after Discontinuing Treatment.Turkish journal of ophthalmology · 2023Article
- Ocular surface disease: a known yet overlooked side effect of topical glaucoma therapy.Frontiers in toxicology · 2023Review
- Shortening of interpupillary distance after topical prostaglandin analog eye drop application in an ophthalmic surgeon: A case report.American journal of ophthalmology case reports · 2022Article
- Recovery of deepening of the upper eyelid sulcus after switching from prostaglandin FP receptor agonists to EP2 receptor agonist: a 3-month prospective analysis.Japanese journal of ophthalmology · 2021Observational
- Corneal topographic changes after blepharoptosis surgery in patients with deepening of the upper eyelid sulcus.Japanese journal of ophthalmology · 2021Article
- Decreased orbital fat and enophthalmos due to bimatoprost: Quantitative analysis using magnetic resonance imaging.PloS one · 2019Observational
- Periorbital changes associated with prostaglandin analogs in Korean patients.BMC ophthalmology · 2017Article
- Effects of pre-surgical administration of prostaglandin analogs on the outcome of trabeculectomy.PloS one · 2017Article
- Patient considerations in ocular hypertension: role of bimatoprost ophthalmic solution.Clinical ophthalmology (Auckland, N.Z.) · 2017Review
- Prostaglandin-associated periorbitopathy in latanoprost users.Clinical ophthalmology (Auckland, N.Z.) · 2015Article
- Incidence of deepening of the upper eyelid sulcus in prostaglandin-associated periorbitopathy with a latanoprost ophthalmic solution.Eye (London, England) · 2014Article
- Switching efficacy on intraocular pressure from latanoprost to bimatoprost in eyes with open angle glaucoma: implication to the changes of central corneal thickness.Japanese journal of ophthalmology · 2014Article
- Preservative-free latanoprost eye drops in patients with primary open-angle glaucoma/ocular hypertension.Clinical drug investigation · 2014Review
- Incidence of deepening of the upper eyelid sulcus on treatment with a tafluprost ophthalmic solution.Japanese journal of ophthalmology · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeAlthough useful for reducing intraocular pressure (IOP), bimatoprost (BIM) can cause deepening of the upper eyelid sulcus (DUES), one of the symptoms of prostaglandin-associated periorbitopathy (PAP). We investigated recovery from BIM-induced DUES after switching treatment to latanoprost (LAT).
designProspective, observer-masked, open-label study.
methodsTwenty-five Japanese patients suffering from primary open-angle glaucoma treated with LAT in both eyes for longer than 6 months and requiring further IOP reduction were prospectively enrolled in the study. During the first 6 months after the switch to BIM, 15 of the 25 patients (60 %) developed DUES. Among these patients, 13 were switched back to LAT and re-examined for DUES at 2-month intervals for an additional 6 months.
resultsTwo months after the switch back to LAT, for 11 of the 13 patients (85 %) the DUES symptoms had either decreased or disappeared, and this was maintained for at least 6 months. During this time, 6 of 8 patients (75 %) subjectively positive for DUES self-reported a decrease in DUES.
conclusionsAlthough DUES is a frequent side effect of treatment with BIM, switching to LAT may reverse the condition for most patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.